Table 3.
How to use specific available medication during preconception period.
| Medication | Pre-Conception | References |
|---|---|---|
| Hydroxychloroquine | Recommended to all patients | [5,15,46] |
| Oral glucocorticoids | Accepted if needed at lowest effective dose, but less than 20 mg/day equivalent Prednisone | [5,15,46] |
| Azathioprine | Accepted if needed | [5,15,46] |
| Cyclosporin A and tacrolimus | Accepted if needed, caution if high blood pressure | [5,15,46] |
| Nonsteroidal antiinflamatory drugs | Accepted if needed, discontinue if there is problem with conceiving, cyclooxygenase 2 not indicated | [5,15,46] |
| Methotrexate | Stop 1–3 months prior to conception | [5,15,46] |
| Leflunomide | Stop if planning a pregnancy, washout with cholestyramine until no longer detected | [5,15,46] |
| Mycophenolate Mofetil and Mycophenolic Acid | Stop at least 6 weeks before conception to observe flare after discontinuation | [5,15,46] |
| Cyclophosphamide | Stop 3 months prior to conception | [5,15,46] |
| Available biologics (Belimumab, Rituximab) | Discontinue at conception | [15] |
| Recently approved biologic (Anifrolumab) | Not yet included in EULAR and ACR recommendations, no available data related to safety during pregnancy |
EULAR—European Alliance of Associations for Rheumatology; ACR—American College of Rheumatology.